Generation Bio Co. financial data

Symbol
GBIO on Nasdaq
Location
301 Binney Street, Cambridge, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 628 % -11.7%
Debt-to-equity 178 % +59.2%
Return On Equity -94.8 % +9.57%
Return On Assets -34.1 % +31.1%
Operating Margin -457 % +46%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.74M shares -89.9%
Common Stock, Shares, Outstanding 6.74M shares -89.9%
Entity Public Float 155M USD -48.2%
Common Stock, Value, Issued 1K USD -85.7%
Weighted Average Number of Shares Outstanding, Basic 6.74M shares +0.92%
Weighted Average Number of Shares Outstanding, Diluted 6.74M shares +0.92%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 15.3M USD -17.8%
Research and Development Expense 68M USD -7.8%
General and Administrative Expense 37.3M USD -12.2%
Operating Income (Loss) -69.8M USD +55.6%
Nonoperating Income (Expense) 10.7M USD -10.3%
Net Income (Loss) Attributable to Parent -62.6M USD +56.9%
Earnings Per Share, Basic 0 USD/shares +64.2%
Earnings Per Share, Diluted 0 USD/shares +64.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 21.9M USD +1.31%
Marketable Securities, Current 67.7M USD -58.5%
Accounts Receivable, after Allowance for Credit Loss, Current 391K USD -82.3%
Other Assets, Current 160K USD -44.8%
Assets, Current 93.5M USD -51.1%
Property, Plant and Equipment, Net 8.85M USD -44.7%
Operating Lease, Right-of-Use Asset 17.4M USD -17.9%
Other Assets, Noncurrent 0 USD -100%
Assets 122M USD -51%
Accounts Payable, Current 2.06M USD +24.4%
Employee-related Liabilities, Current 10.3M USD +129%
Contract with Customer, Liability, Current 5.68M USD
Liabilities, Current 21M USD -30.3%
Contract with Customer, Liability, Noncurrent 55.1M USD
Operating Lease, Liability, Noncurrent 19.7M USD -76.2%
Other Liabilities, Noncurrent 0 USD
Liabilities 71.3M USD -50.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 8K USD -97.5%
Retained Earnings (Accumulated Deficit) -744M USD -9.19%
Stockholders' Equity Attributable to Parent 50.6M USD -51.6%
Liabilities and Equity 122M USD -51%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -28.4M USD +10.5%
Net Cash Provided by (Used in) Financing Activities -125K USD -100%
Net Cash Provided by (Used in) Investing Activities 2.96M USD
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 6.74M shares -89.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 24.1M USD +1.19%
Deferred Tax Assets, Valuation Allowance 214M USD +22.1%
Operating Lease, Liability 62M USD
Payments to Acquire Property, Plant, and Equipment 246K USD -87.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -62.9M USD +56.6%
Lessee, Operating Lease, Liability, to be Paid 137M USD +31.1%
Property, Plant and Equipment, Gross 38.2M USD -16%
Operating Lease, Liability, Current 6.35M USD -41.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 15.6M USD +2.83%
Lessee, Operating Lease, Liability, to be Paid, Year One 15.2M USD +13.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 38.9M USD -13.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 16.1M USD +2.92%
Deferred Tax Assets, Operating Loss Carryforwards 105M USD +8.37%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 16.6M USD +2.83%
Operating Lease, Payments 1.9M USD -38.7%
Additional Paid in Capital 795M USD +1.15%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 4.86M USD -5.64%
Deferred Tax Assets, Net of Valuation Allowance 222M USD +12.4%
Share-based Payment Arrangement, Expense 8.84M USD -49.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%